New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...
Until recently, the root cause of cachexia was identified as the inflammatory mediators produced either by the tumour itself ...
Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...
COLUMBIA, Mo.--(BUSINESS WIRE)--Endevica Bio, a company developing best-in-class peptide drug candidates with better safety and efficacy properties, presented new data from a recent preclinical study ...
Certain cancers cause people to weaken and waste away. A mouse model of this points to tumour-induced blockade of molecules that normally protect muscle innervation and mass. Will the discovery lead ...
Kalohexis, a newly created biotechnology company to advance the clinical development of a portfolio of drug candidates harnessing the melanocortin (MC) system for the treatment of metabolic disorders ...
New research shows cachexia – involuntary weight loss and muscle wasting due to illness – is an important, but underrecognized, syndrome in people with lupus. Of the 2,406 people with lupus assessed, ...
In cachexia, liver metabolism is fundamentally reprogrammed. One gene, which normally regulates the liver’s activity throughout the day, ceases to function properly. Using a mouse model, the ...
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.
Please provide your email address to receive an email when new articles are posted on . Patients with cancer cachexia assigned ponsegromab gained significantly more weight than those assigned placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results